Younis, S., Barnier-Quer, C., Heuking, S., Sommandas, V., Brunner, L., Werff, N., … Remarque, E. (2018). Down selecting adjuvanted vaccine formulations: a comparative method for harmonized evaluation. BMC Immunology, 19(1), 6. https://doi.org/10.1186/s12865-018-0245-0 (Original work published 2018)
adjuvants
Van Den Eeckhout, B., Van Hoecke, L., Burg, E., Van Lint, S., Peelman, F., Kley, N., … Gerlo, S. (2020). Specific targeting of IL-1β activity to CD8+ T cells allows for safe use as a vaccine adjuvant. NPJ Vaccines, 5(1), 64. https://doi.org/10.1038/s41541-020-00211-5 (Original work published 2020)
Van Den Eeckhout, B., Huyghe, L., Van Lint, S., Burg, E., Plaisance, S., Peelman, F., … Tavernier, J. (2021). Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication. Journal for Immunotherapy of Cancer, 9(11). https://doi.org/10.1136/jitc-2021-003293 (Original work published 2021)